Imiglucerase

CHEBI:CHEBI_754706

Drug Classification

Important Medical Information

⚕️ This information is sourced from ChEBI (Chemical Entities of Biological Interest) database and is intended for educational purposes only.

  • Always consult with a healthcare professional before starting, stopping, or modifying any medication.
  • Side effects may vary and this list may not be comprehensive.
  • Drug interactions may occur with other medications.

Additional Identifiers

🔍 Click on any linked disease name to learn more about the conditions this medication is used to treat, or explore related drug classifications for more information about similar medications.

Additional Attributes

rxcui
1726268
generic_name
IMIGLUCERASE
product_type
DRUG FOR FURTHER PROCESSING
listing_expiration_date
20251231
dosage_form
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
route
INTRAVENOUS
marketing_category
DRUG FOR FURTHER PROCESSING
labeler_name
Genzyme Corporation
marketing_start_date
19940523
manufacturer_name
Genzyme Corporation
nui
M0009360
pharm_class_epc
Hydrolytic Lysosomal Glucocerebroside-specific Enzyme [EPC]
pharm_class
Glucosylceramidase [CS]
pharm_class_cs
Glucosylceramidase [CS]
product_ndc
58468-4663
spl_id
d03983de-2774-4ca8-8c30-5161846f6e5c
active_ingredient_name
IMIGLUCERASE
active_ingredient_strength
40 U/mL
package_ndc
58468-4663-1
package_description
1 VIAL, GLASS in 1 CARTON (58468-4663-1) / 10 mL in 1 VIAL, GLASS
package_marketing_start_date
19940523
brand_name
Cerezyme
brand_name_base
Cerezyme
application_number
BLA020367
unii
Q6U6J48BWY
spl_set_id
df60f030-866b-4374-a31f-8ae3f6b45c38
22-rdf-syntax-ns#type
http://www.w3.org/2002/07/owl#Class